Saturday, December 24, 2005


Viral Hepatitis C - Oakland Briefs


Oakland Briefs
Detroit News - A house fire that killed a 44-year-old Milford Township man early Thursday remains under investigation. Firefighters were called to the fire at 251 Our Land Acres Drive about 11 p.m. Wednesday. A woman managed to escape the house and advised

Viral Hepatitis C - Hepatitis C Virus Transmission


Hepatitis C Virus Transmission
An overview of the general population in the United States and modes of transmission. This document is primarily directed at the VA healthcare provider. ... Some modes of transmission of hepatitis C virus are well documented and widely accepted; others are less ... nucleic acid amplification of the hepatitis C virus, which will detect the ...

MedlinePlus: Hepatitis C
features links to news and articles about HCV infection, its symptoms and diagnosis, treatment options, prevention, alternative therapies, and support organizations.

Friday, December 23, 2005


Viral Hepatitis C - Hep C Palace


Hep C Palace
Hepatitis C information, chat and support for people with HCV, their friends and family.

Hep C Connection
A newsletter for people interested in or suffering from hepatitis C.

Viral Hepatitis C - }


}
SUSTAINED ALT RESPONSE RATE VS DURATION OF THERAPY IN CHRONIC HEPATITIS C PATIENTS INTRON A 3 Million IU TIW Treatment Group* Number of Patients (%) INTRON A 3 million IU Difference

Management of Chronic Hepatitis C: Clinical Focus
Management of Chronic Hepatitis C Summary (Publication No. 02-E029, June 2002) Evidence Report (Publication No. 02-E030, June 2002) ( PDF File , 2.3 MB) Evidence-based Practice Center: Johns Hopkins

Sloan-Kettering - Find a Clinical Trial
Phase II Study of Sho-saiko-to in Patients with Chronic Hepatitis C Who Cannot Use Interferon [Protocol 02-073] Find a Clinical Trial Full Title : SHO-SAIKO-TO FOR PATIENTS WITH CHRONIC HEPATITIS

Viral Hepatitis C - MedlinePlus: Hepatitis C


MedlinePlus: Hepatitis C
Hepatitis C. ... Overviews; Frequently Asked Questions about Hepatitis C (National Center for Infectious Diseases) Also available in: Spanish · Hepatitis C ...

Hepatitis C: Hepatitis C Council Of Victoria
Hepatitis C News, Information and Resources and Support.

hepCuk.info
The main online resource for Hepatitis C in the UK. ... 0870 200 1 200 HEPATITIS C TELEPHONE HELPLINE 0870 200 1 200 Staffed by volunteers who have or have ...

Thursday, December 22, 2005


Viral Hepatitis C - Controversies in Liver Transplantation


Controversies in Liver Transplantation
Medscape News - Current controversies in liver transplantation continue to revolve around the disparity between available deceased donor organs and maximizing the available donor pool, difficult clinical scenarios of patient selection given limited donor resources

South Africa: Heading for a Bumper Year
AllAfrica.com - THE South African market for commercial vehicles of more than 3500kg Gross Vehicle Mass (GVM) surged ahead during November to record the second highest single month's sales return in the history of this market. The total sales of 2733 units reported

Tata Motors sales up by 9.1 pc in Nov'05, exports up by 35 pc
Newz.in - Tata Motors reported total sales of 34,282 vehicles (including exports) for the month of November this year as compared to 31,428 vehicles sold in November last year, a growth of 9.1 per cent. However, the company's exports grew by huge 35 per cent

Viral Hepatitis C - Hepatitis C Virus Lives In Your Liver(NC)-Your liver works 24

Hepatitis C Virus Lives In Your Liver

(NC)-Your liver works 24 hours a day, performing over 500 vital functions for your body. Most of the blood that returns to your heart passes through the liver. Your body can't function without it.

The hepatitis C virus lives in your liver. It inflames liver cells, which, over time, affects the way your liver functions. The effect of the hepatitis C virus varies from person to person. There is no way to predict how your body will react to it. There are, however, some things that are known:

You can live with hepatitis C for many years without experiencing any major symptoms, or you might simply feel tired. Symptoms can come and go over time. Their presence or absence does not tell you the degree to which liver damage may or may not be occurring. p>

Chronic, long-term inflammation of the liver can cause liver cell damage and result in fibrosis (liver scarring), or even cirrhosis. This damage can occur in as little as five years, or as long as 30 years.

About 20% of chronic hepatitis patients develop cirrhosis within 10 to 20 years.

Use of recreational drugs or alcohol can speed up inflammation and the development of fibrosis or cirrhosis.

There is an increased risk of liver cancer in people with cirrhosis.

The good news is that current drug treatments can be very effective for people with hepatitis C. Combined with proper nutrition, plenty of rest, and avoidance of recreational drugs and alcohol, these treatments help many who have the virus lead relatively healthy lives.

If you think you may be at risk of getting hepatitis C, see your doctor. The virus can be detected by a simple blood test. For more information on how to keep your liver happy and healthy, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

p>

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. p>


Wednesday, December 21, 2005


Viral Hepatitis C - Feedster


Feedster
No Need to Click Here - I'm just claiming my feed at Feedster....

Tuesday, December 20, 2005


Viral Hepatitis C - Hepatitis C - Page 1


Hepatitis C - Page 1
and the development of antibody screening tests, the number of newly acquired acute

National Hepatitis C Coalition Inc. - Offering Hope For Hepatitis C
many of our government institutions want us to believe are the only ones at risk for

Article Search Engine: GoArticles.com

The National Institutes of Health (NIH) Consensus Development Program
following

Monday, December 19, 2005


Viral Hepatitis C - Hepatitis C: Hepatitis C Council Of Victoria


Hepatitis C: Hepatitis C Council Of Victoria
Hepatitis C News, Information and Resources and Support.

VA National Hepatitis C Program
The Veterans Affairs National Hepatitis C Web site provides information about viral hepatitis for health care providers inside and outside the VA system,

Hepatitis Central, Current Information On Hepatitis C & treatments
Hepatitis C Information Center at Hepatitis-Central.com Featuring the latest news about Hepatitis C infection, Hepatitis C diagnosis, Hepatitis C symptoms,

HCV Advocate.org
Up-to-date and accurate information about treatment hepatitis C. Can a Person with Hepatitis C Purchase Insurance? (2005)

Viral Hepatitis C - Hepatitis Information Network: HepNet - Hepatitis C


Hepatitis Information Network: HepNet - Hepatitis C
How significant is hepatitis C infection in Canada? by M. Sherman, Hepatologist. High risk Individuals - Who are they? Slide Show: Seroprevalence and Risk

Viral Hepatitis C - A Summary of Chronic Hepatitis C InfectionHepatitis C is a

A Summary of Chronic Hepatitis C Infection

Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.

Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.

Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.

The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.

Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.

Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.

Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.

Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.

About the Author

Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.

Sunday, December 18, 2005


Viral Hepatitis C - SciClone Reports Results from First ZADAXIN Phase 3


SciClone Reports Results from First ZADAXIN Phase 3
Pharma Live - SAN MATEO, Calif. -- December 14, 2005 -- SciClone Pharmaceuticals, Inc. ( with pegylated interferon alpha to treat patients with

Do Type and Duration of Antiretroviral Therapy Reduce the Severity of Liver Disease in HIVHCV Coinfected Patie
HIV and Hepatitis.com - is turning to care for individuals living with HIV who are coinfected with

EU scientists seek big investment in nanomedicine
ABCNEWS.com - to carry tumor-killing agents into cells, while